Direct Effect of Vanadium on Citrate Uptake by Rat Renal Brush Border Membrane Vesicles (BBMV)

Vanadium pentoxide is used as a catalyst and a ferrovanadium alloy ingredient in automotive steels and in jet engines and airframes. In addition, vanadium is found in fuel oils. Thus, occupational exposures to vanadium pentoxide and trioxide may occur during the cleaning of oil-fired ship boilers, a...

Full description

Saved in:
Bibliographic Details
Published inIndustrial Health Vol. 40; no. 3; pp. 278 - 281
Main Authors SATO, Kazuhiro, KUSAKA, Yukinori, AKINO, Hironobu, KANAMARU, Hiroshi, OKADA, Kenichiro
Format Journal Article
LanguageEnglish
Published Japan National Institute of Occupational Safety and Health 01.07.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Vanadium pentoxide is used as a catalyst and a ferrovanadium alloy ingredient in automotive steels and in jet engines and airframes. In addition, vanadium is found in fuel oils. Thus, occupational exposures to vanadium pentoxide and trioxide may occur during the cleaning of oil-fired ship boilers, and from oil-fired power station boilers. Occupational exposure to vanadium pentoxide induces green tongue, asthmatic symptoms and albuminuria with cast. Urinary citrate is freely filtered at the glomerulus, and its reabsorption in the proximal tubule is the major determinant of the rate of renal excretion. In this study, we exposed rat renal brush border membrane vesicles (BBMV) to vanadium pentoxide and examined their citrate uptake characteristics. The preincubation of BBMV with 1 mM V2O5 for 8 hours significantly inhibited citrate uptake compared with that of BBMV without V2O5 preincubation. These findings indicate that the preincubation of BBMV with vanadium pentoxide results in a time-dependent inhibition of citrate uptake by BBMV. These findings might contribute to nephrotoxicity in vanadium exposure.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0019-8366
1880-8026
DOI:10.2486/indhealth.40.278